Korro Bio Inc, a RNA therapeutics company, has secured $91.5 million in Series A financing. Wu Capital led the round with participation from other investors that included Atlas Venture, New Enterprise Associates, Qiming Venture Partners USA, Surveyor Capital, Cormorant Asset Management, MP Healthcare Venture Management and Alexandria Venture Investments.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: